Plant Health Care plc

Financial performance has remained strong, with revenue growing from $2.80M in Q1 2023 to $5.69M in Q4 2023. Gross profit continued to perform well, with margins at 60% in the latest quarter. Operating income reached -$2.07M in Q4 2023, holding a steady -36% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at -$1.68M. Net income dropped to -$1.43M, keeping EPS at -$0.004. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.